Dr. Raghvendra A. Bohara, MSc, PhD, is an Assistant Professor at the Centre for Interdisciplinary Research, D. Y. Patil Education Society (Deemed to be University), Kolhapur, India, and a Government of Ireland IRC Postdoctoral Fellow at CÚRAM, National University of Ireland Galway. He collaborates closely with Prof. Abhay Pandit and has established research partnerships with colleagues across India, South Korea, Japan, Taiwan, Ireland, the USA, Germany, Poland, Saudi Arabia, and Australia. Dr. Bohara has received several prestigious fellowships and awards for his research contributions. He is actively involved in teaching, supervising doctoral students, and participating in outreach and scientific dissemination. He serves as Associate Editor for Biochemistry and Biophysics Reports (Elsevier), has experience as a guest editor and reviewer, and holds key roles in research ethics and innovation at his institution. His main research interests are magnetic-triggered drug delivery and cancer nanomedicine Dr. Nanasaheb Thorat is Principal Investigator funded by the Science Foundation Ireland (SFI) and Irish Research Council (IRC) Pathway Program at the University of Limerick, Ireland. He is also a Marie Curie Visiting Research Scientist at the University of Oxford, UK.He has been deeply engaged in collaborative work with the many eminent scientists from Japan, USA, Germany, Korea, Ireland, India, Poland, Saudi Arabia and Australia. Dr. Thorat has received the European Commission’s innovation Radar “Grand Prix of the Innovation Radar Prize 2020” for developing ground-breaking technology for breast cancer theranostics.

• 1. Introduction and types of hybrid nanostructures for medical applications2. Synthesis, functionalization and bioconjugation of hybrid nanostructures: mechanisms for improved bioactivity3. Pros and cons of current cancer therapy4. Bio distribution and Cellular Interaction of Hybrid Nanostructures 5. Nanopharmacological study of hybrid nanostructures6. Nanostructures for Externally Triggered Chemo-Thermal Therapies7. Hyperthermia Therapy Using Hybrid Magnetic nanostructures8. Hybrid Nanostructures in Targeted Drug Delivery9. Hybrid nanostructures in diagnostic approach: a comprehensive approach to combat cancer10. Hybrid nanostructures for in-vivo imaging11. Shape controlled Hybrid Nanostructures for Cancer Theranostics12. Strengths and limitations of translating the hybrid nanostructures to the clinic

Dr. Raghvendra A. Bohara, MSc, PhD, is an Assistant Professor at the Centre for Interdisciplinary Research, D. Y. Patil Education Society (Deemed to be University), Kolhapur, India, and a Government of Ireland IRC Postdoctoral Fellow at CÚRAM, National University of Ireland Galway. He collaborates closely with Prof. Abhay Pandit and has established research partnerships with colleagues across India, South Korea, Japan, Taiwan, Ireland, the USA, Germany, Poland, Saudi Arabia, and Australia. Dr. Bohara has received several prestigious fellowships and awards for his research contributions. He is actively involved in teaching, supervising doctoral students, and participating in outreach and scientific dissemination. He serves as Associate Editor for Biochemistry and Biophysics Reports (Elsevier), has experience as a guest editor and reviewer, and holds key roles in research ethics and innovation at his institution. His main research interests are magnetic-triggered drug delivery and cancer nanomedicine Dr. Nanasaheb Thorat is Principal Investigator funded by the Science Foundation Ireland (SFI) and Irish Research Council (IRC) Pathway Program at the University of Limerick, Ireland. He is also a Marie Curie Visiting Research Scientist at the University of Oxford, UK.He has been deeply engaged in collaborative work with the many eminent scientists from Japan, USA, Germany, Korea, Ireland, India, Poland, Saudi Arabia and Australia. Dr. Thorat has received the European Commission’s innovation Radar “Grand Prix of the Innovation Radar Prize 2020” for developing ground-breaking technology for breast cancer theranostics.

• 1. Introduction and types of hybrid nanostructures for medical applications2. Synthesis, functionalization and bioconjugation of hybrid nanostructures: mechanisms for improved bioactivity3. Pros and cons of current cancer therapy4. Bio distribution and Cellular Interaction of Hybrid Nanostructures 5. Nanopharmacological study of hybrid nanostructures6. Nanostructures for Externally Triggered Chemo-Thermal Therapies7. Hyperthermia Therapy Using Hybrid Magnetic nanostructures8. Hybrid Nanostructures in Targeted Drug Delivery9. Hybrid nanostructures in diagnostic approach: a comprehensive approach to combat cancer10. Hybrid nanostructures for in-vivo imaging11. Shape controlled Hybrid Nanostructures for Cancer Theranostics12. Strengths and limitations of translating the hybrid nanostructures to the clinic

Dr. Raghvendra A. Bohara, MSc, PhD, is an Assistant Professor at the Centre for Interdisciplinary Research, D. Y. Patil Education Society (Deemed to be University), Kolhapur, India, and a Government of Ireland IRC Postdoctoral Fellow at CÚRAM, National University of Ireland Galway. He collaborates closely with Prof. Abhay Pandit and has established research partnerships with colleagues across India, South Korea, Japan, Taiwan, Ireland, the USA, Germany, Poland, Saudi Arabia, and Australia. Dr. Bohara has received several prestigious fellowships and awards for his research contributions. He is actively involved in teaching, supervising doctoral students, and participating in outreach and scientific dissemination. He serves as Associate Editor for Biochemistry and Biophysics Reports (Elsevier), has experience as a guest editor and reviewer, and holds key roles in research ethics and innovation at his institution. His main research interests are magnetic-triggered drug delivery and cancer nanomedicine Dr. Nanasaheb Thorat is Principal Investigator funded by the Science Foundation Ireland (SFI) and Irish Research Council (IRC) Pathway Program at the University of Limerick, Ireland. He is also a Marie Curie Visiting Research Scientist at the University of Oxford, UK.He has been deeply engaged in collaborative work with the many eminent scientists from Japan, USA, Germany, Korea, Ireland, India, Poland, Saudi Arabia and Australia. Dr. Thorat has received the European Commission’s innovation Radar “Grand Prix of the Innovation Radar Prize 2020” for developing ground-breaking technology for breast cancer theranostics.

• 1. Introduction and types of hybrid nanostructures for medical applications2. Synthesis, functionalization and bioconjugation of hybrid nanostructures: mechanisms for improved bioactivity3. Pros and cons of current cancer therapy4. Bio distribution and Cellular Interaction of Hybrid Nanostructures 5. Nanopharmacological study of hybrid nanostructures6. Nanostructures for Externally Triggered Chemo-Thermal Therapies7. Hyperthermia Therapy Using Hybrid Magnetic nanostructures8. Hybrid Nanostructures in Targeted Drug Delivery9. Hybrid nanostructures in diagnostic approach: a comprehensive approach to combat cancer10. Hybrid nanostructures for in-vivo imaging11. Shape controlled Hybrid Nanostructures for Cancer Theranostics12. Strengths and limitations of translating the hybrid nanostructures to the clinic